Baker Bros. Advisors LP Vaxart, Inc. Transaction History

Baker Bros. Advisors LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$5.64 - $23.33 $7.89 Million - $32.6 Million	-1,398,795 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$3.5 - $7.98 $585,641 - $1.34 Million	-167,326 Reduced 10.68%	1,398,795 $7.99 Million
Q3 2020 Nov 16, 2020	SELL	$4.78 - $16.97 $348,940 - $1.24 Million	-73,000 Reduced 4.45%	1,566,121 $10.4 Million
Q2 2020 Aug 14, 2020	BUY	$1.68 - $8.85 $2.75 Million - $14.5 Million	1,639,121 New	1,639,121 $14.5 Million

106

24.9M

77K

45.8K

Ticker VXRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,506,000
Market Cap $84.8M
Description
Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, an oral tablet vaccine, which is in a Phase Ib clinical trial with bivalent oral tablet vaccine for the GI.1...

Get notified when there are updates to the investment portfolio of Baker Bros. Advisors LP, based on Form 13F filings with the SEC.

Stay updated on Baker Bros. Advisors LP with notifications on news.